Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European CubicinĀ® Outcomes Registry and Experience
Crossref DOI link: https://doi.org/10.1007/s12325-015-0267-4
Published Online: 2015-11-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seaton, R. Andrew
Menichetti, Francesco
Dalekos, Georgios
Beiras-Fernandez, Andres
Nacinovich, Francisco
Pathan, Rashidkhan
Hamed, Kamal http://orcid.org/0000-0003-1896-9736
Funding for this research was provided by:
Novartis Pharma AG